November 18th 2021
Pamela Kunz, MD, discusses the importance of tailoring treatments to individual patients with neuroendocrine tumors.
January 16th 2015
Pamela L. Kunz, MD, assistant professor, Division of Oncology, Stanford University School of Medicine, discusses the impact of the approval of lanreotide.